Cargando…
Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
PURPOSE: To determine the effect of ranibizumab on visual acuity (VA) following a 3-year treatment period for patients diagnosed with wet age-related macular degeneration. To establish whether baseline VA and injection frequency influence visual outcomes. PATIENTS AND METHODS: Retrospective review o...
Autores principales: | Razi, Faraz, Haq, Adnaan, Tonne, Prabhu, Logendran, Maharatnam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762441/ https://www.ncbi.nlm.nih.gov/pubmed/26937168 http://dx.doi.org/10.2147/OPTH.S97775 |
Ejemplares similares
-
Successful Treatment of Retinal Angiomatous Proliferation with Intravitreal Triamcinolone and Ranibizumab Injections in a 67-Year-Old Male
por: Haq, Adnaan, et al.
Publicado: (2014) -
Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
por: Kaya, Abdullah
Publicado: (2016) -
Baseline Predictors of Visual Acuity Outcome in Patients with Wet Age-Related Macular Degeneration
por: Zhang, Xinyuan, et al.
Publicado: (2018) -
The effects of ranibizumab injections on fluorescein angiographic findings and visual acuity recovery in age-related macular degeneration
por: Gungel, Hulya, et al.
Publicado: (2014) -
FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)